SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Crawford P, Appleton R, Betts T, et al. Guidelines for management of women with epilepsy. Seizure 1999;8: 20117.
  • 2
    Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence-based medicine: what it is and what it isn't. Br Med J 1996;312: 712.
  • 3
    Anon. The periodic health examination. Canadian Task Force on the periodic health examination. Can Med Assoc J 1979;121: 193254.
  • 4
    Betts T, Crawford P. Women and Epilepsy. London , UK : Martin Dunitz, 1998: pp. 278.
  • 5
    Lobo RA. A disorder without identity: ‘HCA’, ‘PCO’, ‘PCOD’.‘PCOS’, ‘SLS’. What are we to call it? Fertil Steril 1995;63: 115860.
  • 6
    Isojarvi JIT, Laatikainen TJ, Knip M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39: 57984.
  • 7
    Isojarvi JIT, Laatikainen TJ, Pakarinen AJ, et al. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329: 13838.
  • 8
    Isojarvi J, Rattya J, Knip M, et al. Replacing valproate with lamotrigine reduces cardiovascular risks and insulin mediated hyperandrogenism in women with epilepsy [Abstract]. Epilepsia 1997;38(suppl 3):. 279.
  • 9
    Lefevre F, Betts T. Do women who have hormonal evidence of the polycystic ovary syndrome while taking sodium valproate lose it if they switch to another anticonvulsant? Epilepsia 2004;45(suppl 7):231.
  • 10
    Bilo L, Meo R, Valentino R, et al. Abnormal pattern of luteinising hormone pulsatility in women with epilepsy. Fertil Steril 1991;55: 70511.
  • 11
    Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatility secretion of luteinising hormone in women with epilepsy. Neurology 1994;44: 30610.
  • 12
    Herzog AG. PCOS in women with epilepsy: epileptic or iatrogenic. Ann Neurol 1996;39: 55960.
  • 13
    Artama M, Isojarvi JI, Raitanen J, et al. Birth rate among patients with epilepsy: a nationwide population based cohort study in Finland. Am J Epidemiol 2004;159: 105763.
  • 14
    Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy. Epilepsia 1993;34: 82731.
  • 15
    Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38: 10828.
  • 16
    Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976;54: 32147.
  • 17
    Neme SB, Foldvary-Schaefer NR. Lamotrigine concentrations across the menstrual cycle in women with catamenial epilepsy. Epilepsia 2004;45(suppl 7):125.
  • 18
    Rosciszewska D, Buntner B, Guz I, et al. Ovarian hormones, anticonvulsant drugs and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 1986;49: 4751.
  • 19
    Kumar G, Behari M, Ahuja GK, et al. Phenytoin levels in catamenial epilepsy. Epilepsia 1988;29: 1558.
  • 20
    Shavit G, Lerman P, Korczyn AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 1984;34: 95961.
  • 21
    Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995;45: 1662.
  • 22
    Dana-Haeri J, Richens A. Effects of norethisterone on seizures associated with menstruation. Epilepsia 1983;24: 37781.
  • 23
    Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984;47: 127982.
  • 24
    Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988;38: 43244.
  • 25
    Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002;16: 26372.
  • 26
    Data on File. Research Triangle Park , NC : GlaxoSmithKline.
  • 27
    Stodieck SRG, Schwenkhagen AM. Lamotrigine plasma levels and combined monophasic oral contraceptives or a contraceptive vaginal ring, a prospective evaluation in 30 women. Epilepsia 2004;45(suppl 7):187.
  • 28
    Schwenkhagen AM, Stodieck SRG. Interaction between lamotrigine and progesten—only contraceptive pill containing desogestrel 75 μg (Cerazette). Epilepsia 2004;45(suppl 7):144.
  • 29
    Nakane Y, Okuma T, Takahishi R, et al. Multi-institutional study on the teratogenicity and fetal toxicity of anticonvulsants: a report of a collaborative study group in Japan. Epilepsia 1980;21: 66380.
  • 30
    Morrow J, Craig J. Epilepsy, pregnancy and the advent of pregnancy registers. Prog Neurol Psychiatry 2004;248.
  • 31
    Vajda FJ, O'Brien TJ, Hitchcock A, et al. Australian pregnancy register of women on antiepileptic drugs: 5-year results. Epilepsia 2004;45(suppl 7):234.
  • 32
    Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70: 1521.
  • 33
    Lindhout D, Omtzigt JGC, Cornel MC. Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992;42(suppl 5):1118.
  • 34
    Montouris G. Safety of the new antiepileptic drug box oxcarbazepine with during pregnancy. Cur Med Res Opin 2005;21: 693701.
  • 35
    Gaily E, Granstrom ML, Hiilesmaa V, et al. Minor abnormalities in children of mothers with epilepsy. J Pediatr 1988;112: 5209.
  • 36
    Jager-Roman E, Deichl A, Jacob S, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986;108: 9971004.
  • 37
    Adab N, Kini U, Vinten JA, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75: 157583.
  • 38
    Granstrom ML, Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology 1992;42(suppl 5):1448.
  • 39
    Berkovic SR, Howell RA, Hay DA, et al. Epilepsies in twins: genetics of et al major epilepsy syndromes. Ann Neurol 1998;43: 43545.
  • 40
    Tomson T. Seizure control during pregnancy and delivery. In: TomsonT, GramL, SillanpaaM, et al., eds. Epilepsy and Pregnancy. Chichester , UK : Wrightson Biomedical Publishing Ltd, 1997: pp. 11323.
  • 41
    Schmidt D, Ganger R, Avanzini G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 1983;46: 7515.
  • 42
    Licht EA, Sankar R. Status epileptic during pregnancy: a case report. J Reprod Med 1999;44: 3702.
  • 43
    Clarkson P, James A. Parenteral vitamin K: the effective prophylaxis against haemorrhagic disease for all newborn infants. N Z Med J 1990;103: 956.
  • 44
    Sabers A. Complications during pregnancy and delivery. In: TomsonT, GramL, SillanpaaM, et al, eds. Epilepsy and Pregnancy. Chichester , UK : Wrightson Biomedical Publishing Ltd, 1997: pp 10511.
  • 45
    Yerby MS. Contraception, pregnancy and lactation in women with epilepsy. Baillieres Clin Neurol 1996;5: 887908.
  • 46
    Bardy A. Epilepsy and Pregnancy, A Prospective Study of 154 Pregnancies in Epileptic Women. Helsinki , Finland : University of Helsinki, 1982.
  • 47
    Patsalos PN, Duncan JS. Antiepileptic drugs: a review of clinically significant drug interactions. Drug Saf 1993;9: 15686.
  • 48
    Ito S, Moretti M, Liau M, Koren G. Initiation and duration of breast-feeding in women receiving antiepileptic drugs. Am J Obstet Gynecol 1995;172: 8816.
  • 49
    Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between breast differences in two patients. Eur J Pharmacol 1988;35: 21720.
  • 50
    Fleishaker JC, Desai N, McNamara PJ. Factors affecting the milk to plasma drug concentration ratio in lactating women: physical interactions with protein and fat. J Pharmacol Sci 1987;76: 18993.
  • 51
    Nau H, Kuhnz W, Egger HJ, et al. Anticonvulsants during pregnancy and lactation: transplacental, maternal and neonatal pharmacokinetics. Clin Pharmacokinet 1982;7: 50843.
  • 52
    Liporace J, Kao A, D'Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav 2004;5: 1025.
  • 53
    Ohman I, Vitols S, Thomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate during lactation. Epilepsia 2000;41: 70913.
  • 54
    Greenhill L, Betts T, Yarrow H, et al. Breast milk levels of levetiracetam after delivery. Epilepsia 2004;45(suppl 7):230.
  • 55
    Betts T, Fox C. Evaluation of a preconception clinic for women with epilepsy. Seizure 1999;8: 3227.
  • 56
    Harden CL. Menopause and bone density issues for women with epilepsy. Neurology 2003;61: S1622.
  • 57
    Abbasi F, Krumholz A, Kittner SJ, et al. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999;40: 20510.
  • 58
    Crawford P, Lee P. Gender difference in the management of epilepsy What women are hearing? Seizure 1999;8: 1359.
  • 59
    Harden C, Nikolov B, Labar D, et al. Effect of hormone replacement on seizure frequency in menopausal women with epilepsy. Epilepsia 2004;45(suppl 7):230.
  • 60
    Elliott JO, Darby JM, Jacobson MP. Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsia 2004;45(suppl 7):258.